The vaccine safety task force is being revived under the National Institutes of Health (NIH) following the appointment of CDC director Susan Monarez. NIH Director Jay Bhattacharya emphasized the commitment to rigorous science and innovation. The move has been met with praise from anti-vaccine groups but has raised concerns among health experts. Experts fear that reinstating the task force may convey a message that vaccine safety has not been thoroughly assessed, despite ongoing evaluations. Health officials stress the importance of balancing vaccine risks with the real dangers posed by infectious diseases.
NIH is proud to lead this effort to advance vaccine safety and support innovation that protects children without compromise. By reinstating this Task Force, we are reaffirming our commitment to rigorous science, continuous improvement, and the trust of American families.
What I am concerned about is making sure that we don't overemphasize very small risks [of vaccines] and underestimate the real risk of infectious diseases and cancers that these vaccines help prevent.
I am concerned that bringing this committee back implies to the public that we have not been looking at vaccine safety. The reality is, we evaluate the safety of vaccines more than any other medication, medical intervention, or supplements available.
The task force shall consist of the Director of the National Institutes of Health, the Commissioner of the Food and Drug Administration, and the Director of the Centers for Disease Control [and Prevention].
Collection
[
|
...
]